Concepedia

Author

Xenophon Yataganas

National and Kapodistrian University of Athens

Also Known As

X A Yataganas, X Yataganas, X. A. YATAGANAS, X. YATAGANAS, X. Yataganas, XENOPHON A. YATAGANAS, XENOPHON YATAGANAS, Xenophon A. Yataganas, Xenophon Yataganas, Yataganas X.

97

Publications

2.1K

Citations

25

H-Index

111

Concepts

All Affiliations

National and Kapodistrian University of AthensHammersmith HospitalLaiko General Hospital of AthensMemorial Sloan Kettering Cancer CenterGeneral Hospital of Athens G. Genimatas
XY

About

Xenophon Yataganas is an author at National and Kapodistrian University of Athens specializing in medicine, hematology, and health sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

16

21

623

2

Health Sciences

10

10

361

3

Natural Sciences

4

4

107

4

Engineering

3

3

60

5

Law

3

3

53

Xenophon Yataganas

×

43

Publications

1.8K

Citations

23

H-Index

YearCitations

Soluble receptor activator of nuclear factor κB ligand–osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index

Evangelos Terpos, Richard Szydlo, Jane F. Apperley,

Blood

2003

410

Prolonged administration of erythropoietin increases erythroid response rate in myelodysplastic syndromes: a phase II trial in 281 patients

Evangelos Terpos, Athina Mougiou, Alexandra Kouraklis,

British Journal of Haematology

2002

108

Tartrate‐resistant acid phosphatase isoform 5b: A novel serum marker for monitoring bone disease in multiple myeloma

Evangelos Terpos, Josu de la Fuente, Richard Szydlo,

International Journal of Cancer

2003

106

Prognostic evaluation of the microvascular network in myelodysplastic syndromes

Penelope Korkolopoulou, Effie Apostolidou, PM Pavlopoulos,

Leukemia

2001

84

Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study

Penelope Korkolopoulou, Nora Viniou, Nikolaos Kavantzas,

Leukemia

2003

80

Effect of pamidronate administration on markers of bone turnover and disease activity in multiple myeloma

Evangelos Terpos, John Palermos, Konstantinos Tsionos,

European Journal Of Haematology

2000

71

Pamidronate is superior to ibandronate in decreasing bone resorption, interleukin‐6 and β<sub>2</sub>‐microglobulin in multiple myeloma

Evangelos Terpos, Nora Viniou, Josu de la Fuente,

European Journal Of Haematology

2003

54

Microfluorimetric evaluation of cell kill kinetics with 1-beta-D-arabinofuranosylcytosine.

Xenophon Yataganas, A Strife, Amaury G. Perez,

PubMed

1974

51

DNA, RNA and hemoglobin during erythroblast maturation

Xenophon Yataganas, Gösta Gahrton, B. Thorell

Experimental Cell Research

1970

47

Comparison of allogeneic stem cell transplantation, high‐dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia

Apostolia M. Tsimberidou, Niki Stavroyianni, Nora Viniou,

Cancer

2003

42

Page 1